HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 10033120651

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10033120651 and manufactured by BECKMAN COULTER, INC.. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until Apr 18, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10033120651
2 Related Devices
Registration Details
ANVISA Registration Number: 10033120651
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10033120651

25351605822201062

42160812000144

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Apr 18, 2011

18/04/2026

09/18/2025 19:00:01

Registration Details

10033120651

25351605822201062

42160812000144

Dates and Status

Apr 18, 2011

18/04/2026

09/18/2025 19:00:01